Use of a flexible thiopyrylium photosensitizer and competitive inhibitor for pathogen reduction of viruses and bacteria with retention of red cell storage properties

Transfusion

Volumn 45, Issue 5, 2005, Pages 752-760

  Wagner, Stephen J ^a   Skripchenko, Andrey ^b   Cincotta, Louis ^b   Thompson Montgomery, Dedeene ^b   Awatefe, Helen ^b  

^a AMERICAN RED CROSS   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; DIPYRIDAMOLE; DYE; GLUCOSE; LACTIC ACID; PHOTOSENSITIZING AGENT; THIOPYRYLIUM DYE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIUM CONTAMINATION; BOVINE DIARRHEA VIRUS; CONTROLLED STUDY; ERYTHROCYTE PRESERVATION; GLUCOSE UTILIZATION; HEMOLYSIS; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; NONHUMAN; PH MEASUREMENT; POTASSIUM TRANSPORT; PSEUDORABIES HERPETOVIRUS; VESICULAR STOMATITIS VIRUS; VIRAL CONTAMINATION; VIRUS INACTIVATION;

ANILINE COMPOUNDS; BACTERIA; BACTERIAL INFECTIONS; BLOOD PRESERVATION; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; HEMOLYSIS; HUMANS; PHOTOSENSITIZING AGENTS; PYRANS; VIRUS DISEASES; VIRUSES;

EID: 18544368131     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2005.04188.x     Document Type: Article

References (41)

1. Dodd RY, Notari EP, Stramer SL. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 2002;42:975-9.
2. Dobroszycki J, Herwaldt BL, Boctor F, et al. A cluster of transfusion-associated babesiosis cases traced to a single asymptomatic donor. JAMA 1999;281:927-30.
3. Herwaldt BL, Neitzel DF, Gorlin JB, et al. Transmission of Babesia microti in Minnesota through four blood donations from the same donor over a 6-month period. Transfusion 2002;42:1154-8.
4. Kjemtrup AM, Lee B, Fritz CL, et al. Investigation of transfusion transmission of a WA1-type babesial parasite to a premature infant in California. Transfusion 2002;42:1482-7.
5. Cimo PL, Luper WE, Scouros MA. Transfusion-associated Chagas' disease in Texas: report of a case. Tex Med 1993;89:48-50.
6. Leiby DA, Lenes BA, Tibbals MA, Tames-Olmedo MT. Prospective evaluation of a patient with Trypanosoma cruzi infection transmitted by transfusion. N Engl J Med 1999;341:1237-9.
7. Wagner SJ, Storry JR, Mallory DA, et al. Red cell membrane alterations associated with virucidal methylene blue phototreatment. Transfusion 1992;33:30-6.
8. Abe H, Wagner SJ. Analysis of viral DNA, protein, and envelope damage after methylene blue, phthalocyanine derivative or merocyanine 540 photosensitization. Photochem Photobiol 1995;61:402-9.
9. Skripchenko A, Robinette D, Wagner SJ. Comparison of methylene blue and methylene violet for photoinactivation of intracellular and extracellular virus in red cell suspensions. Photochem Photobiol 1997;65:451-5.
10. Abe H, Wagner SJ, Kuwabara M, Kamo N, Ikebuchi K, Sekiguchi S. Factors affecting M13 bacteriophage inactivation by methylene blue photosensitization. Photochem Photobiol 1997;65:873-6.
11. Wagner SJ, Skripchenko A, Robinette D, Foley JW, Cincotta L. Factors affecting virus photoinactivation by a series of phenothiazine dyes. Photochem Photobiol 1998;67:343-9.
12. Wagner SJ, Skripchenko A, Robinette D, Mallory DA, Cincotta L. Preservation of red cell properties after virucidal phototreatment with dimethylmethylene blue. Transfusion 1998;38:729-37.
13. Besselink GA, Van Engelenburg FA, Korsten HG, et al. The band III ligand dipyridamole protects human RBCs during photodynamic treatment while extracellular virus inactivation is not affected. Transfusion 2002;42:728-33.
14. Wagner S, Skripchenko A, Thompson-Montgomery D. Use of a flow-cell system to investigate virucidal dimethylmethylene blue phototreatment in two RBC additive solutions. Transfusion 2002;42:1200-5.
15. Wagner SJ, Skripchenko A, Thompson-Montgomery D. Quinacrine enhances vesicular stomatitis virus inactivation and diminishes hemolysis of dimethylmethylene blue phototreated cells. Photochem Photobiol 2002;76:514-7.
16. Bowen BP, Enderlein J, Woodbury NW. Single-molecule fluorescence spectroscopy of TOTO on poly-AT and poly-GC DNA. Photochem Photobiol 2003;78:576-81.
17. Ackerman B, Tuite E. Single- and double-strand photo-cleavage of DNA by YO, YOYO and TOTO. Nucleic Acids Res 1996;24:1080-90.
18. Yamamoto N, Okamoto T, Kawaguchi M. Novel intercalators of pyrylium dye into double-stranded DNA. Nucleic Acids Symp Ser 1993;29:83-4.
19. Yamamoto N, Okamoto T, Miyazaki T, Kawaguchi M. Fluorescent stain containing pyrylium salt and fluorescent staining method of biological sample. US patent 6,022,961. 2000.
20. Okamoto T, Yamamoto N, Kawaguchi M. Pharmaceutical compositions containing pyrylium compounds, pyrylium salts and process for manufacturing a medicament containing the aforesaid compounds. US patent 6,242,477,B1. 2001.
21. Hardy JD, Kurrus FD, Chavez CM, et al. Evaluation of a coronary vasodilator, dipyridamole (Persantin). JAMA 1964;188:1141.
22. Iuliano L, Pedersen JZ, Rotilio G, Ferro D, Violi F. A potent chain-breaking antioxidant activity of the cardiovascular drug dipyridamole. Free Rad Biol Med 1995;18:239-47.
23. Iuliano L, Ghiselli A, Alessandri C, Bonavita MS, Violi F. Superoxide anion scavenging property of dipyridamole. Thromb Haemost 1989;61:149.
24. Kusmic C, Picano E, Busceti CL, Petersen C, Barsacchi R. The antioxidant drug dipyridamole spares the vitamin E and thiols in red blood cells after oxidative stress. Cardiovasc Res 2000;47:510-4.
25. Grinstein S, Ship S, Rothstein A. Anion transport in relation to proteolytic dissection of band 3 protein. Biochim Biophys Acta 1978;507:294-304.
26. vanSteveninck J, Trannoy LL, Besselink GA, et al. Selective protection of RBCs against photodynamic damage by the band 3 ligand dipyridamole. Transfusion 2000;40:1330-6.
27. Hogman CF, Eriksson L, Gong J, et al. Half-strength citrate CPD combined with a new additive solution for improved storage of red blood cells suitable for clinical use. Vox Sang 1993;65:271-8.
28. Federico M, Titti F, Butto S, et al. Biologic and molecular characterization of producer and nonproducer clones from HUT-78 cells infected with a patient HIV isolate. AIDS Res Hum Retroviruses 1989;5:385-96.
29. Wagner SJ, Skripchenko A, Pugh JC, Suchmann DB, Ijaz MK. Duck hepatitis B photoinactivation by dimethylmethylene blue in RBC suspensions. Transfusion 2001;41:1154-8.
30. Pugh JC, Mason WS, Simmons H. Susceptibility to duck hepatitis B virus infection is associated with the presence of cell surface receptor sites that efficiently bind virus particles. J Virol 1995;69:4814-22.
31. Reed LJ, Muench HA. A simple method of estimating fifty percent end points. Am J Hyg 1938;27:493-7.
32. Yamada O, Hattori N, Kurimura T, Kita M, Kishida T. Inhibition of growth of HIV by human natural Interferon in vitro. AIDS Res Hum Retroviruses 1988;4:287-94.
33. Beutler E. Red cell metabolism: a manual of biochemical methods. 3rd ed. Orlando (FL): Grune & Stratton; 1984.
34. Standefer JC, Vanderjagt D. Use of tetramethylbenzidine in plasma hemoglobin assay. Clin Chem 1977;23:749-51.
35. Usry RT, Moore GL, Manalo FW. Morphology of stored, rejuvenated human erythrocytes. Vox Sang 1975;28:176-83.
36. Guidance for industry: Q5A viral safety evaluation of biotechnology products derived from cell lines of human or animal origin [Internet]. Appendix 3. Rockville (MD): Center for Drug Evaluation and Research, U.S. Food and Drug Administration; 1998 Sep. Available from: http//http://www.fda.gov/cder/ guidance/Q5A-fnl.pdf
37. Ben-Hur E, Chan WS, Yim Z, et al. Photochemical decontamination of red blood cell concentrates with the silicon phthalocyanine PC 4 and red light. Dev Biol Stand 2000;102:149-55.
38. Wagner SJ, Skripchenko A. Investigation of photosensitizing dyes for pathogen reduction in red cell suspensions. Biotech Histochem 2003;78:171-7.
39. Skripchenko AA, Wagner SJ. Idenfication of the target responsible for M13 virus inactivation by dimethylmethylene blue and light treatment [Abstract 2265]. Blood 2001;98S:541a.
40. Pooler JP. The kinetics of colloid osmotic hemolysis. II. Photohemolysis. Biochim Biophys Acta 1985;812:199-205.
41. Besselink GA, Ebbing IG, Hilarius PM, et al. Composition of the additive solution affects red blood cell integrity after photodynamic treatment. Vox Sang 2003;85:183-9.